http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010146547-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d744495a72db4f1d2465358610b0c691 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17596cb58229204e29f19810017a007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d4acf8e67a810f332df5921d82fc7f5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-16 |
filingDate | 2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d68a1ff58b0ffe166a2a0ac420491d11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2089f0ad2a352adbae177b71c995513 |
publicationDate | 2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2010146547-A1 |
titleOfInvention | Tellurium-containing compounds for facilitating transplantation |
abstract | A method of reducing a level of an anli-HLA antibody in a subject in need of organ transplantation may comprise administering to the subject a therapeutically effective amount of a tellurium-containing compound. The tellurium-containing compound may have at least one tellurium dioxo moiety and may have a general formula selected from the group consisting of tellurium dioxide (TeO 2 ), a complex of TeO 2 , and compounds having general formulas such that AS101 is one specific example of one of the general formulas. Also disclosed are methods of using such tellurium-containing compounds in preparing medicaments for use in reducing a level of an anti-HLA antibody in a subject in need of organ transplantation. Pharmaceutical compositions comprising tellurium-containing compounds for organ transplantation are also disclosed. |
priorityDate | 2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.